Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Warren

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Environmental Toxicology and Chemistry|May 5, 2009
Evaluation of dicloran's contribution to the mutagenic activity of Cristais River, Brazil, water samplesDanielle Palma de Oliveira, Maureen Sakagami, Sarah Warren, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Nucleus accumbens sub-regions experience distinct dopamine release responses following acute and chronic morphine exposureSarah Warren Gooding, Elinor Lewis, Christine Chau, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
Occupational Therapy International|March 18, 2022
Canadian Occupational Performance Measure: Benefits and Limitations Highlighted Using the Delphi Method and Principal Component AnalysisJean-Michel Caire, Sabrina Maurel-Techene, Thierry Letellier, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2012
Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancerJacqueline Vuky, Huong T Pham, Sarah Warren, et al.
Molecular and Cellular Biology|December 17, 2008
Nuclear export of NBN is required for normal cellular responses to radiationChristine S Vissinga, Tiong C Yeo, Sarah Warren, et al.
Oncotarget|November 17, 2016
Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case reportMiguel H Bronchud, Francesc Tresserra, Wenjie Xu, et al.
Journal for Immunotherapy of Cancer|June 23, 2018
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4Sergey A Trushin, Alicia Algeciras-Schimnich, Stacey R Vlahakis, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers CommitteeAnne Monette, Sarah Warren, J Carl Barrett, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Environmental Toxicology and Chemistry|May 5, 2009
Evaluation of dicloran's contribution to the mutagenic activity of Cristais River, Brazil, water samplesDanielle Palma de Oliveira, Maureen Sakagami, Sarah Warren, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Nucleus accumbens sub-regions experience distinct dopamine release responses following acute and chronic morphine exposureSarah Warren Gooding, Elinor Lewis, Christine Chau, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
Occupational Therapy International|March 18, 2022
Canadian Occupational Performance Measure: Benefits and Limitations Highlighted Using the Delphi Method and Principal Component AnalysisJean-Michel Caire, Sabrina Maurel-Techene, Thierry Letellier, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2012
Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancerJacqueline Vuky, Huong T Pham, Sarah Warren, et al.
Molecular and Cellular Biology|December 17, 2008
Nuclear export of NBN is required for normal cellular responses to radiationChristine S Vissinga, Tiong C Yeo, Sarah Warren, et al.
Oncotarget|November 17, 2016
Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case reportMiguel H Bronchud, Francesc Tresserra, Wenjie Xu, et al.
Journal for Immunotherapy of Cancer|June 23, 2018
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)Patrick Danaher, Sarah Warren, Rongze Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4Sergey A Trushin, Alicia Algeciras-Schimnich, Stacey R Vlahakis, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers CommitteeAnne Monette, Sarah Warren, J Carl Barrett, et al.
Pageof 9